Modulate Therapeutics Overview
- Year Founded
-
2015
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Modulate Therapeutics General Information
Description
Developer of therapeutics drugs designed to treat neoplastic diseases. The company's drugs increase the presence of tumor-infiltrating lymphocytes while blocking a key mediator of immunosuppression in the tumor micro-environment for patients suffering from different cancer indications, enabling healthcare providers to improve the lives of cancer patients.
Contact Information
Corporate Office
- 1255 Boul Robert-Bourassa Bureau
- Suite 1610
- Montreal, Quebec H3B 3X3
- Canada
Corporate Office
- 1255 Boul Robert-Bourassa Bureau
- Suite 1610
- Montreal, Quebec H3B 3X3
- Canada
Modulate Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 06-Oct-2023 | Completed | Startup | |||
| 1. Early Stage VC (Series A) | 24-Dec-2015 | Completed | Startup |
Modulate Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Modulate Therapeutics FAQs
-
When was Modulate Therapeutics founded?
Modulate Therapeutics was founded in 2015.
-
Where is Modulate Therapeutics headquartered?
Modulate Therapeutics is headquartered in Montreal, Canada.
-
What industry is Modulate Therapeutics in?
Modulate Therapeutics’s primary industry is Drug Discovery.
-
Is Modulate Therapeutics a private or public company?
Modulate Therapeutics is a Private company.
-
What is Modulate Therapeutics’s current revenue?
The current revenue for Modulate Therapeutics is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
